Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

JCA is underway…what it really means for rare disease evidence

Introduction This article first appeared in the Rare Focus newsletter on LinkedIn (October 2025). The EU Joint Clinical[…]

EU JCA 2025 Explained: What Rare Disease Sponsors Need to Know Now

The EU Joint Clinical Assessment (JCA) is one of the most significant changes to hit market access in years.[…]

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept